Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of treating APOL-1 dependent focal segmental glomerulosclerosis

US Patent 11801234 · Granted Oct 31, 2023

Estimated economic value: $257,235,000

Assignee

Inventors

View full patent text on Google Patents →